Antimicrobial resistance surveillance of bacteria in 1999 in Korea with a special reference to resistance of enterococci to vancomycin and Gram-negative bacilli to third generation cephalosporin, imipenem, and fluoroquinolone

被引:24
作者
Lee, K
Lee, HS
Jang, SJ
Park, AJ
Lee, H
Song, WK
Chong, YS
机构
[1] Yonsei Univ, Coll Med, Dept Clin Pathol, Seoul, South Korea
[2] Chonbuk Natl Univ, Sch Med, Dept Clin Pathol, Chonju, South Korea
[3] Chosun Univ Hosp, Dept Clin Pathol, Kwangju, South Korea
[4] Chung Ang Univ, Coll Med, Dept Clin Pathol, Seoul 156756, South Korea
[5] Vet Hosp, Dept Clin Pathol, Seoul, South Korea
[6] Hallym Univ, Coll Med, Dept Clin Pathol, Seoul, South Korea
关键词
antimicrobial drug resistance in Korea; resistance surveillance; vancomycin-resistant enterococci; impenem-resistant Pseudomonas;
D O I
10.3346/jkms.2001.16.3.262
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The trend of antimicrobial resistance of bacteria isolated from patients in 30 Korean hospitals in 1999 was analyzed with a particular attention to cefotaximeor fluoroquinolone-resistant gram-negative bacilli, imipenem-resistant Pseudomonas aeruginosa, and vancomycin-resistant enterococci. Adequacy of susceptibility testing, and any change in the frequencies of isolated species were also analyzed. The results showed that only 20% and 30% of hospitals tested the piperacillin-tazobactam and cefoxitin susceptibility of Enterobacteriaoeae, respectively, only 24% of hospitals the piperacillin-tazobactam susceptibility of P. aeruginosa, and 17% of hospitals the fusidic acid susceptibility of staphylococci. Among the isolates 26.3% were glucose-nonfermenting gram-negative bacilli. and 34.7% of Enterococcus were Enterococcus faecium, Slight decline of cefotaxime-resistance rate to 20% was noted in Klebsiella pneumoniae, while fluoroquinolone-resistantce rate was 68% in Acinetobacter baumannii. The ceftazidime- and imipenem-resistance rates were 17% and 18%, respectively in P. aeruginosa, The vancomycin-resistance rate of E. faecium rose significantly to 15.1%, but the rates varied significantly depending on hospitals suggesting presence of different degree of selective pressure or nosocomial spread. In conclusion, the prevalence of imipenem-resistant P. aeruginosa and the increase of vancomycin-resistant E, faecium were the particularly worrisome phenomena observed in this study.
引用
收藏
页码:262 / 270
页数:9
相关论文
共 30 条
[1]   Plasmid-encoded AmpC β-lactamases:: How far have we gone 10 years after the discovery? [J].
Bauernfeind, A ;
Chong, Y ;
Lee, K .
YONSEI MEDICAL JOURNAL, 1998, 39 (06) :520-525
[2]   Analysis of 42 cases of septicemia caused by an epidemic strain of methicillin-resistant Staphylococcus aureus:: Evidence of resistance to vancomycin [J].
Burnie, J ;
Matthews, R ;
Jiman-Fatami, A ;
Gottardello, P ;
Hodgetts, S ;
D'arcy, S .
CLINICAL INFECTIOUS DISEASES, 2000, 31 (03) :684-689
[3]  
BUSH K, 1988, Clinical Microbiology Reviews, V1, P109
[4]   Escherichia coli ATCC 35218 as a quality control isolate for susceptibility testing of Haemophilus influenzae with haemophilus test medium [J].
Butler, DL ;
Jakielaszek, CJ ;
Miller, LA ;
Poupard, JA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (02) :283-286
[5]   Vancomycin-resistant enterococci [J].
Cetinkaya, Y ;
Falk, P ;
Mayhall, CG .
CLINICAL MICROBIOLOGY REVIEWS, 2000, 13 (04) :686-+
[6]   Korean nationwide surveillance of antimicrobial resistance of bacteria in 1997 [J].
Chong, Y ;
Lee, K ;
Park, YJ ;
Jeon, DS ;
Lee, MH ;
Kim, MY ;
Chang, CH ;
Kim, EC ;
Lee, NY ;
Kim, HS ;
Kang, ES ;
Cho, HC ;
Paik, IK ;
Lee, HS ;
Jang, SJ ;
Park, AJ ;
Cha, YJ ;
Kang, SH ;
Lee, MH ;
Song, W ;
Shin, JH .
YONSEI MEDICAL JOURNAL, 1998, 39 (06) :569-577
[7]  
Courvalin P., 1996, CLIN MICROBIOL INFEC, V2, pS11
[8]  
COURVLAIN P, 2000, 7 W PAC C CHEM INF D
[9]  
Demey Hendrik E., 1999, Clin Microbiol Infect, V5 Suppl 1, pS29, DOI 10.1111/j.1469-0691.1999.tb00722.x
[10]  
Donskey CJ, 1999, CLIN INFECT DIS, V29, P573, DOI 10.1086/598636